Key facts
- Rivera.’s last known valuation is $14.0M (Mar 2019).
- It has raised $20.4M; the latest was Later Stage VC ($14.9M) in Jun 2025.
- Notable investors include JobsOhio Ventures, Rev1 Ventures, Blue Heron Capital, MK Capital, Pixel Perfect Ventures — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Rivera.
- ·The full record, as it builds
Funding rounds
No funding rounds for Rivera. are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rivera.
Developer of a pharmacy data analytics platform designed to address billing issues, prevent overpayments, and reduce future discrepancies. The company's platform provides real-time insights into prescription claims and reconciles them with contracts and plan designs, enabling payers and the healthcare sector to control drug spending, improve contract efficiency, and enhance health outcomes through data-driven decisions.
- Sector
- Business Products and Services (B2B)
- HQ
- Columbus, OH, United States
- Founded
- 2010
- Employees
- 32
- Website
- riverarx.com/
- Ownership
- Privately Held (backing)
Rivera. doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rivera. shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rivera. in its N-PORT filings yet. We sweep new filings monthly.